TW · Healthcare

YungShin Global Holding Corp (3705)

Drug Manufacturers - Specialty & Generic

YungShin Global Holding Corp (3705) is listed on TW in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 3705

P/E ratio

18.00

YungShin Global Holding Corp (3705) — FAQ

What is 3705's P/E ratio?

The price-to-earnings (P/E) ratio for YungShin Global Holding Corp (3705) is 18.00 (data as of 2026-05-23).

Does YungShin Global Holding Corp pay a dividend?

Dividend yield is not available in the current snapshot for YungShin Global Holding Corp (3705). Check the MyAverix Finance app for the latest dividend data.

What sector is YungShin Global Holding Corp in?

YungShin Global Holding Corp (3705) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 3705 listed on?

3705 is listed on TW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)